Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.
Bertin L, Barberio B, Gubbiotti A, Bertani L, Costa F, Ceccarelli L, Visaggi P, Bodini G, Pasta A, Sablich R, Urbano MT, Ferronato A, Buda A, De Bona M, Del Corso G, Massano A, Angriman I, Scarpa M, Zingone F, Savarino EV.
Bertin L, et al. Among authors: bertani l.
J Clin Med. 2024 Mar 7;13(6):1539. doi: 10.3390/jcm13061539.
J Clin Med. 2024.
PMID: 38541765
Free PMC article.